You leave the clinic with numbers that are “almost” high.
Your cholesterol is slightly elevated.
Your blood pressure is creeping up.
Your doctor says, “Let’s monitor it.”
You are not high risk.
But you are not clearly low risk either.
This is the gray zone in cardiology. It is where heart disease often quietly begins, and where many people are left unsure about what to do next.
Heart disease remains the leading cause of death in the United States. According to the CDC, it accounts for nearly 700,000 deaths each year. At the same time, diagnostic error remains a recognized patient safety issue across American healthcare.
A landmark 2023 study published in BMJ Quality & Safety estimated that approximately 1 in 20 U.S. adults experiences a diagnostic error annually. The authors estimated diagnostic errors may contribute to roughly 371,000 deaths and 424,000 permanent disabilities each year in the United States.
Life Imaging has tracked similar patterns among individuals seeking preventive scans in Florida.
“A lot of people come to us stuck between ‘normal’ and ‘high risk,’” says founder Tom Graham. “They want a clearer picture, not just a label.”
He adds: “Borderline is not a diagnosis. It’s a warning sign.”
Why “Borderline” Is Not Harmless
Borderline numbers can feel reassuring because they are not extreme. But heart disease does not begin at extremes. It builds slowly.
Plaque can form for years before symptoms appear. Early changes are often invisible on routine lab work. That is one reason delayed or missed diagnoses happen, not just in heart disease, but across serious illnesses.
In recent years, major U.S. media outlets including The New York Times, CNN, and ProPublica have reported extensively on diagnostic delays involving heart attacks, colorectal cancer, and other life-threatening conditions.
One widely covered case involved a young woman whose persistent chest pain was repeatedly attributed to anxiety before later testing revealed significant coronary disease. Other reports have highlighted patients treated for gastrointestinal complaints for months before imaging uncovered advanced colorectal cancer.
These cases are not about blame. They illustrate how early disease often looks ordinary.
That is exactly what makes borderline risk dangerous.
When cholesterol is “almost high” and blood pressure is “almost elevated,” it is easy to assume everything is fine. But biology does not follow guideline cutoffs. Disease progresses on its own timeline.
“Most serious heart events don’t begin with extreme numbers,” Graham says. “They begin in the gray zone.”
Why the Gray Zone Is Where Risk Hides
Heart attacks frequently occur in people who were never classified as high risk.
Research has shown that a substantial proportion of first heart attacks occur in individuals previously considered low or intermediate risk based on standard risk calculators. This phenomenon is known as risk misclassification.
It does not mean the lab was wrong.
It means the estimate did not capture the full picture.
“Borderline numbers can hide real plaque,” Graham says. “That’s why some patients want to look deeper.”
Coronary artery calcium (CAC) scoring is recognized in major U.S. cardiology guidelines, including those from the American College of Cardiology (ACC) and American Heart Association (AHA) — as a tool to refine risk assessment in borderline or intermediate-risk adults. CAC can help determine whether prevention strategies should be intensified or whether reassurance is appropriate.
The Limits of Routine Tests
Cholesterol testing is useful, but it is only part of the risk equation.
Many people who suffer heart attacks have cholesterol and blood pressure levels that were considered borderline or even normal prior to the event. Plaque can be present long before standard numbers trigger treatment.
Blood pressure fluctuates. A single “almost high” reading does not reveal what is happening inside the arteries.
“People hear ‘borderline’ and think it means ‘ignore it,’” Graham says. “At borderline, your attention should go up, not down.”
Risk Stacking: The Hidden Multiplier
Borderline numbers rarely occur in isolation.
- Slightly elevated LDL
- Mildly elevated blood pressure
- Family history of early heart disease
- Sedentary lifestyle
- Poor sleep
Each factor adds to overall risk, even if no single number crosses a treatment threshold.
Life Imaging Reviews frequently reflect this insight. Many individuals report being told for years that their numbers were “almost fine,” only for imaging to reveal early plaque or other structural abnormalities.
“Risk is cumulative,” Graham says. “It’s not just one number.”
When Risk Calculators Aren’t Enough
Physicians often use 10-year risk calculators to estimate heart attack or stroke probability. These tools incorporate age, sex, cholesterol levels, blood pressure, and smoking status.
But borderline results fall into an uncertain space. When a calculated risk lands just below a treatment threshold, decision-making becomes more nuanced.
“Decision-making shouldn’t be guessing,” Graham says. “It should be informed.”
Coronary Artery Calcium Scoring
Coronary artery calcium (CAC) scoring is one method used to refine cardiovascular risk. The test uses a low-dose CT scan to measure calcified plaque in the coronary arteries, a direct indicator of atherosclerosis.
In major studies, CAC scoring has significantly reclassified patient risk, sometimes downward, providing reassurance, and sometimes upward, prompting earlier intervention.
Graham describes this as “risk clarity.”
“Imaging doesn’t create disease,” he says. “It reveals what’s already there.”
The Human Cost of Delayed Diagnosis
Beyond heart disease, delayed diagnosis remains a documented issue in American medicine.
A 2022 report from the Agency for Healthcare Research and Quality (AHRQ) emphasized diagnostic error as an under-recognized contributor to preventable harm. Studies have shown that cancers such as colorectal and lung cancer are sometimes diagnosed at later stages despite prior healthcare visits.
Women in particular may experience atypical heart attack symptoms, which can delay recognition. The American Heart Association has highlighted persistent gaps in early identification of heart disease in women compared to men.
These patterns underscore why borderline risk should not be dismissed.
Borderline is not trivial.
It is a moment to be thoughtful and proactive.
A Practical Plan for Borderline Risk
If your cholesterol or blood pressure is “almost” high, consider:
- Tracking blood pressure at home for 1–2 weeks
- Reviewing your family history for early cardiovascular disease
- Asking about lifetime (not just 10-year) risk
- Discussing additional risk enhancers (inflammation, metabolic syndrome, etc.)
- Considering CAC scoring if clinically appropriate
- Acting early on lifestyle: regular exercise, balanced nutrition, sleep optimization, and tobacco cessation
These steps are not about fear. They are about information and action.
“Borderline isn’t a verdict,” Graham says. “It’s a call to look deeper — while time still matters.”
Peyman Khosravani is a seasoned expert in blockchain, digital transformation, and emerging technologies, with a strong focus on innovation in finance, business, and marketing. With a robust background in blockchain and decentralized finance (DeFi), Peyman has successfully guided global organizations in refining digital strategies and optimizing data-driven decision-making. His work emphasizes leveraging technology for societal impact, focusing on fairness, justice, and transparency. A passionate advocate for the transformative power of digital tools, Peyman’s expertise spans across helping startups and established businesses navigate digital landscapes, drive growth, and stay ahead of industry trends. His insights into analytics and communication empower companies to effectively connect with customers and harness data to fuel their success in an ever-evolving digital world.
